Clinical trials have demonstrated that Wegovy, at its 2.4 mg strength, can result in an average weight loss of 15% over a 68-week period
Generally, short-term oral use is considered safe for healthy adults
If uneven skin tone, dullness, or stubborn dark spots have been on your radar for a while, chances are you've already come across it
Patients with severe obesity (BMI 40), significant comorbid metabolic disease, or family history of type 2 diabetes may benefit from maximum-dose targeting after appropriate titration
it's about gaining energy, improving metabolic health, and building sustainable habits
10.17925/EE.2015.11.01.21 14 HalawiH.KhemaniD.EckertD.O'NeillJ.KadouhH.GrotheK.et al (2017)